(G) Genpact - Overview
Stock: Outsourcing, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.50% |
| Yield on Cost 5y | 1.73% |
| Yield CAGR 5y | 12.01% |
| Payout Consistency | 58.5% |
| Payout Ratio | 25.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | -17.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -28.92 |
| Character TTM | |
|---|---|
| Beta | 0.675 |
| Beta Downside | 0.615 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.61% |
| CAGR/Max DD | -0.10 |
Description: G Genpact January 06, 2026
Genpact Limited (NYSE:G) is a Bermuda-incorporated provider of business process outsourcing (BPO) and information-technology services, operating across India, the rest of Asia, North and Latin America, and Europe.
The firm is organized into three operating segments: Financial Services, Consumer & Healthcare, and High-Tech & Manufacturing. Each segment delivers end-to-end solutions ranging from customer onboarding and loan processing to supply-chain planning, digital commerce, and engineering support.
Key performance indicators from the most recent fiscal year show revenue of roughly **$4.0 billion**, a **5 % year-over-year growth** driven largely by digital-transformation contracts, and an **operating margin near 13 %** after continued investment in AI-enabled automation.
Sector-level drivers that underpin Genpage’s outlook include accelerating demand for **cloud-based BPO services**, heightened regulatory compliance spending in financial services, and the **near-shoring trend** that pushes U.S. firms to outsource to lower-cost but high-skill locations such as India and Eastern Europe.
Analysts note that Genpact’s **backlog of signed contracts grew 8 % YoY**, indicating a robust pipeline that could sustain earnings growth even if macro-economic conditions soften.
For a deeper, data-rich assessment of Genpact’s valuation dynamics, you might explore the company’s profile on ValueRay to see how its risk-adjusted metrics compare to peers.
Piotroski VR‑10 (Strict, 0-10) 10.0
| Net Income: 551.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 2.23 > 1.0 |
| NWC/Revenue: 14.99% < 20% (prev 23.71%; Δ -8.72% < -1%) |
| CFO/TA 0.14 > 3% & CFO 729.4m > Net Income 551.3m |
| Net Debt (688.3m) to EBITDA (887.4m): 0.78 < 3 |
| Current Ratio: 1.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (176.1m) vs 12m ago -2.63% < -2% |
| Gross Margin: 35.82% > 18% (prev 0.35%; Δ 3547 % > 0.5%) |
| Asset Turnover: 93.72% > 50% (prev 87.59%; Δ 6.13% > 0%) |
| Interest Coverage Ratio: 11.47 > 6 (EBITDA TTM 887.4m / Interest Expense TTM 69.1m) |
Altman Z'' 2.96
| A: 0.14 (Total Current Assets 2.21b - Total Current Liabilities 1.46b) / Total Assets 5.36b |
| B: 0.26 (Retained Earnings 1.37b / Total Assets 5.36b) |
| C: 0.15 (EBIT TTM 793.0m / Avg Total Assets 5.34b) |
| D: 0.20 (Book Value of Equity 552.8m / Total Liabilities 2.82b) |
| Altman-Z'' Score: 2.96 = A |
Beneish M -2.96
| DSRI: 1.00 (Receivables 1.32b/1.23b, Revenue 5.01b/4.66b) |
| GMI: 0.99 (GM 35.82% / 35.41%) |
| AQI: 1.09 (AQ_t 0.52 / AQ_t-1 0.48) |
| SGI: 1.07 (Revenue 5.01b / 4.66b) |
| TATA: -0.03 (NI 551.3m - CFO 729.4m) / TA 5.36b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of G shares?
Over the past week, the price has changed by -8.41%, over one month by -14.70%, over three months by +5.60% and over the past year by -17.00%.
Is G a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the G price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51.2 | 26.7% |
| Analysts Target Price | 51.2 | 26.7% |
| ValueRay Target Price | 40.5 | 0.2% |
G Fundamental Data Overview February 03, 2026
P/E Forward = 18.315
P/S = 1.5342
P/B = 3.0227
P/EG = 1.7
Revenue TTM = 5.01b USD
EBIT TTM = 793.0m USD
EBITDA TTM = 887.4m USD
Long Term Debt = 827.0m USD (from longTermDebt, last quarter)
Short Term Debt = 437.5m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 688.3m USD (from netDebt column, last quarter)
Enterprise Value = 8.37b USD (7.69b + Debt 1.43b - CCE 740.8m)
Interest Coverage Ratio = 11.47 (Ebit TTM 793.0m / Interest Expense TTM 69.1m)
EV/FCF = 12.97x (Enterprise Value 8.37b / FCF TTM 645.5m)
FCF Yield = 7.71% (FCF TTM 645.5m / Enterprise Value 8.37b)
FCF Margin = 12.89% (FCF TTM 645.5m / Revenue TTM 5.01b)
Net Margin = 11.01% (Net Income TTM 551.3m / Revenue TTM 5.01b)
Gross Margin = 35.82% ((Revenue TTM 5.01b - Cost of Revenue TTM 3.21b) / Revenue TTM)
Gross Margin QoQ = 36.37% (prev 35.88%)
Tobins Q-Ratio = 1.56 (Enterprise Value 8.37b / Total Assets 5.36b)
Interest Expense / Debt = 0.89% (Interest Expense 12.8m / Debt 1.43b)
Taxrate = 22.98% (43.5m / 189.4m)
NOPAT = 610.7m (EBIT 793.0m * (1 - 22.98%))
Current Ratio = 1.51 (Total Current Assets 2.21b / Total Current Liabilities 1.46b)
Debt / Equity = 0.56 (Debt 1.43b / totalStockholderEquity, last quarter 2.54b)
Debt / EBITDA = 0.78 (Net Debt 688.3m / EBITDA 887.4m)
Debt / FCF = 1.07 (Net Debt 688.3m / FCF TTM 645.5m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.31% (Net Income 551.3m / Total Assets 5.36b)
RoE = 22.11% (Net Income TTM 551.3m / Total Stockholder Equity 2.49b)
RoCE = 23.88% (EBIT 793.0m / Capital Employed (Equity 2.49b + L.T.Debt 827.0m))
RoIC = 16.39% (NOPAT 610.7m / Invested Capital 3.73b)
WACC = 7.19% (E(7.69b)/V(9.11b) * Re(8.40%) + D(1.43b)/V(9.11b) * Rd(0.89%) * (1-Tc(0.23)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.00%
[DCF Debug] Terminal Value 82.59% ; FCFF base≈596.1m ; Y1≈670.4m ; Y5≈897.6m
Fair Price DCF = 102.8 (EV 18.42b - Net Debt 688.3m = Equity 17.73b / Shares 172.4m; r=7.19% [WACC]; 5y FCF grow 14.47% → 2.90% )
EPS Correlation: -7.70 | EPS CAGR: -44.52% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.31 | Revenue CAGR: 5.08% | SUE: 1.17 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.92 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=11
EPS next Year (2026-12-31): EPS=3.95 | Chg30d=+0.003 | Revisions Net=+3 | Growth EPS=+9.2% | Growth Revenue=+7.0%